{"id":2197,"date":"2026-10-16T21:24:43","date_gmt":"2026-10-16T21:24:43","guid":{"rendered":"https:\/\/chatscopeai.com\/news\/health-canada-issues-guides-on-tougher-drug-shortage-reporting-rules\/"},"modified":"2026-10-16T21:24:44","modified_gmt":"2026-10-16T21:24:44","slug":"health-canada-issues-guides-on-tougher-drug-shortage-reporting-rules","status":"publish","type":"post","link":"https:\/\/chatscopeai.com\/news\/health-canada-issues-guides-on-tougher-drug-shortage-reporting-rules\/","title":{"rendered":"Health Canada Issues Guides on Tougher Drug Shortage Reporting Rules"},"content":{"rendered":"\n<p class=\"wp-block-paragraph hsn-lede\">Health Canada published four guides on its drug shortage rules, which require most discontinuations to be reported at least 12 months ahead.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Health Canada has published four new and updated guides that explain how drug companies must meet its tougher drug shortage rules. The rules already apply, and companies must now report most planned discontinuations at least 12 months ahead.<\/strong><\/p>\n<p class=\"wp-block-paragraph\">The guides were released on Oct. 16, 2026, in Health Canada&#8217;s Drug Establishment Licensing Bulletin 198<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\" id=\"hsn-cite-1\">1<\/a><\/sup>. They cover shortage and discontinuation reporting, emergency imports of substitute drugs, exports, and longer expiry dates. A virtual information session for companies is set for <strong>Oct. 21, 2026<\/strong><sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>At a glance<\/th><th>Details<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>What was published<\/td><td>Four guidance documents on amended drug shortage rules<\/td><\/tr>\n<tr><td>Published on<\/td><td>16 October 2026<\/td><\/tr>\n<tr><td>Who must comply<\/td><td>Drug makers holding a drug identification number, and holders of establishment licences<\/td><\/tr>\n<tr><td>Effective date<\/td><td>Rules in force since 17 June 2026<\/td><\/tr>\n<tr><td>Next milestone<\/td><td>Virtual information session on 21 October 2026<\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<h2 class=\"wp-block-heading\">What is new in this release?<\/h2>\n<p class=\"wp-block-paragraph\">The underlying rules are not new. Health Canada published the amended regulations, numbered SOR\/2026-96, in the Canada Gazette on June 17, 2026, and they took effect that day<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The Gazette, Canada&#8217;s official record of new regulations, lists them as registered on May 29, 2026<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\" id=\"hsn-cite-2\">2<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">What is new is the practical guidance. Health Canada says the documents help regulated companies meet the requirements in the Food and Drug Regulations<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The four guides are:<\/p>\n<ul>\n<li><strong>GUI-0120<\/strong>: reporting and providing information on drug shortages and discontinuations<\/li>\n<li><strong>GUI-0148<\/strong>: exceptional importation and sale of drugs in response to shortages and discontinuations<\/li>\n<li><strong>GUI-0145<\/strong>: distributing drugs meant for the Canadian market for use outside Canada<\/li>\n<li><strong>GUI-0500<\/strong>: extending expiration dates of marketed drugs during shortages<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\">The department says the regulations aim to protect people in Canada from the harm caused by health product shortages<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">Earlier notice of discontinued drugs<\/h2>\n<p class=\"wp-block-paragraph\">The biggest change for drug makers is timing. A company that decides to stop selling a drug more than 12 months out must post notice <strong>at least 12 months before<\/strong> the stop date<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. If the stop date is 12 months away or less, it must post notice within <strong>five days<\/strong> of the decision<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">Notices go on a designated public website, in both English and French<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. If posted details change, the company must update them within five days<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">A separate rule covers drugs that simply stop selling. If a maker has not sold a drug for 12 months, it must tell the health minister in writing within 30 days<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>Situation<\/th><th>What the company must do<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Stop date more than 12 months away<\/td><td>Post notice at least 12 months before<\/td><\/tr>\n<tr><td>Stop date 12 months away or less<\/td><td>Post notice within 5 days of deciding<\/td><\/tr>\n<tr><td>Discontinuation details change<\/td><td>Update within 5 days<\/td><\/tr>\n<tr><td>Drug not sold for 12 months<\/td><td>Notify the minister within 30 days<\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<h2 class=\"wp-block-heading\">Shortage reporting and a wider list of drugs<\/h2>\n<p class=\"wp-block-paragraph\">When a shortage exists or is likely, the maker must post details on the designated website<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. If it expects a shortage to begin within six months, it must post within <strong>five days<\/strong> of that finding<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. It must update changed details within two days, and post within two days once it can meet demand again<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">The rules also widen which drugs are covered. Health Canada can now add drugs such as over-the-counter medicines to an Expanded Scope List<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. It can do so when a shortage or discontinuation of those drugs could risk injury to human health<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. Listed drugs then face the same shortage reporting rules and limits on sales outside Canada<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">Health Canada may also ask makers and licence holders for information when a shortage could risk health<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. They must answer in the time and manner the minister sets<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">Emergency imports to fill gaps<\/h2>\n<p class=\"wp-block-paragraph\">The exceptional importation framework lets licensed companies bring in foreign-approved drugs during a shortage. The amended rules widen it in three ways<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>:<\/p>\n<ul>\n<li>Drugs made in Canada but approved only abroad may now be sold at home.<\/li>\n<li>Imports are allowed for more shortages, including over-the-counter drugs, where health is at risk.<\/li>\n<li>A substitute drug can be imported for <strong>up to 36 months<\/strong> after a Canadian drug is discontinued.<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\">An importer must notify the minister at least three business days before the drug arrives<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. Health Canada can limit sales of listed drugs to named health professionals and licence holders<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. Sellers must give users safe-use information at the time of sale<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. They must also report serious adverse drug reactions and certain foreign actions such as recalls<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">Longer expiry dates during shortages<\/h2>\n<p class=\"wp-block-paragraph\">A new framework lets Health Canada extend the expiry dates of specific drug lots or batches<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. It applies when a shortage, or risk of one, could harm human health<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. Those lots go on an Extended Expiration Date List, and may be sold until the new date<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">Exports and record keeping<\/h2>\n<p class=\"wp-block-paragraph\">Licence holders who ship drugs for use outside Canada face a record-keeping duty. They must immediately create a detailed record of the information showing the export is not prohibited<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. Guide GUI-0145 covers this area<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">Key terms in plain words<\/h2>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>Term<\/th><th>Meaning<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Drug identification number<\/td><td>The number Health Canada assigns to each drug approved for sale<\/td><\/tr>\n<tr><td>Discontinuation<\/td><td>When a maker permanently stops selling a drug in Canada<\/td><\/tr>\n<tr><td>Establishment licence<\/td><td>A Health Canada licence to make, import or distribute drugs<\/td><\/tr>\n<tr><td>Exceptional importation<\/td><td>Bringing in a foreign-approved drug to cover a Canadian shortage<\/td><\/tr>\n<tr><td>Expanded Scope List<\/td><td>Health Canada&#8217;s list of extra drugs brought under shortage rules<\/td><\/tr>\n<tr><td>Canada Gazette<\/td><td>The government&#8217;s official publication for new regulations<\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<p class=\"wp-block-paragraph\">Health Canada&#8217;s Health Product Shortages Directorate will hold its virtual information session on <strong>Oct. 21, 2026<\/strong>, from 2:30 p.m. to 3:30 p.m. EST<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading hsn-refs-title\">Sources<\/h2>\n<ol class=\"hsn-refs\">\n<li id=\"hsn-ref-1\"><a class=\"hsn-refs__back\" href=\"#hsn-cite-1\" aria-label=\"Back to reference 1 in the text\">\u21a9<\/a> <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/establishment-licences\/drug-establishment-licensing-bulletin\/new-updated-guidance-documents-drug-shortages.html\" rel=\"noopener\" target=\"_blank\">New and updated guidance documents on drug shortages &#8211; Canada.ca<\/a> <span class=\"hsn-refs__url\">https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/establishment-licences\/drug-establishment-licensing-bulletin\/new-updated-guidance-documents-drug-shortages.html<\/span><\/li>\n<li id=\"hsn-ref-2\"><a class=\"hsn-refs__back\" href=\"#hsn-cite-2\" aria-label=\"Back to reference 2 in the text\">\u21a9<\/a> <a href=\"https:\/\/gazette.gc.ca\/rp-pr\/p2\/2026\/2026-06-17\/html\/sor-dors96-eng.html\" rel=\"noopener\" target=\"_blank\">Canada Gazette, Part 2, Volume 160, Number 12:\u00a0Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices)<\/a> <span class=\"hsn-refs__url\">https:\/\/gazette.gc.ca\/rp-pr\/p2\/2026\/2026-06-17\/html\/sor-dors96-eng.html<\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Health Canada published four guides on its drug shortage rules, which require most discontinuations to be reported at least 12 months ahead.<\/p>\n","protected":false},"author":1,"featured_media":2195,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_regnews_id":"35791","_hsn_citations":"[{\"n\":1,\"url\":\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/establishment-licences\/drug-establishment-licensing-bulletin\/new-updated-guidance-documents-drug-shortages.html\",\"label\":\"New and updated guidance documents on drug shortages - Canada.ca\"},{\"n\":2,\"url\":\"https:\/\/gazette.gc.ca\/rp-pr\/p2\/2026\/2026-06-17\/html\/sor-dors96-eng.html\",\"label\":\"Canada Gazette, Part 2, Volume 160, Number 12:\u00a0Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices)\"}]","_hsn_no_sources":"","_hsn_content_hash":"34af8f274b26fa99b3281a8d24a12bd4eb43e68a:53e0446c6ca7a9f5106e46c637d5cc30e8b81431","_yoast_wpseo_focuskw":"pharmaceuticals","footnotes":""},"categories":[58,40],"tags":[22],"class_list":["post-2197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-pharma-medical","tag-canada"],"_links":{"self":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts\/2197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/comments?post=2197"}],"version-history":[{"count":1,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts\/2197\/revisions"}],"predecessor-version":[{"id":2199,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts\/2197\/revisions\/2199"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/media\/2195"}],"wp:attachment":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/media?parent=2197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/categories?post=2197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/tags?post=2197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}